These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28534971)

  • 1. miR-483-5p plays a protective role in chronic obstructive pulmonary disease.
    Shen Z; Tang W; Guo J; Sun S
    Int J Mol Med; 2017 Jul; 40(1):193-200. PubMed ID: 28534971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Profiling Reveals a Role for MicroRNA-218-5p in the Pathogenesis of Chronic Obstructive Pulmonary Disease.
    Conickx G; Mestdagh P; Avila Cobos F; Verhamme FM; Maes T; Vanaudenaerde BM; Seys LJ; Lahousse L; Kim RY; Hsu AC; Wark PA; Hansbro PM; Joos GF; Vandesompele J; Bracke KR; Brusselle GG
    Am J Respir Crit Care Med; 2017 Jan; 195(1):43-56. PubMed ID: 27409149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD.
    Tang W; Shen Z; Guo J; Sun S
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2951-2964. PubMed ID: 27932875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression networks in COPD: microRNA and mRNA regulation.
    Ezzie ME; Crawford M; Cho JH; Orellana R; Zhang S; Gelinas R; Batte K; Yu L; Nuovo G; Galas D; Diaz P; Wang K; Nana-Sinkam SP
    Thorax; 2012 Feb; 67(2):122-31. PubMed ID: 21940491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-212-5p exerts a protective effect in chronic obstructive pulmonary disease.
    Jia Q; Chang J; Hong Q; Zhang JJ; Zhou H; Chen FH
    Discov Med; 2018 Nov; 26(144):173-183. PubMed ID: 30695677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of microRNAs in lung homogenates in rats with chronic obstructive pulmonary disease].
    Li B; Zhou X; Chen L; Feng C; Li T
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Dec; 26(12):905-9. PubMed ID: 25476085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers.
    Xie L; Wu M; Lin H; Liu C; Yang H; Zhan J; Sun S
    Mol Biosyst; 2014 May; 10(5):1072-81. PubMed ID: 24556821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral leukocyte microRNAs as novel biomarkers for COPD.
    Wang R; Xu J; Liu H; Zhao Z
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1101-1112. PubMed ID: 28435243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-199a-5p is associated with hypoxia-inducible factor-1α expression in lungs from patients with COPD.
    Mizuno S; Bogaard HJ; Gomez-Arroyo J; Alhussaini A; Kraskauskas D; Cool CD; Voelkel NF
    Chest; 2012 Sep; 142(3):663-672. PubMed ID: 22383663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway.
    Xu H; Wu Y; Li L; Yuan W; Zhang D; Yan Q; Guo Z; Huang W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():627-638. PubMed ID: 28243080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of miRNA-mRNA-lncRNA Networks in Non-Smoking and Smoking Patients with Chronic Obstructive Pulmonary Disease.
    Qian Y; Mao ZD; Shi YJ; Liu ZG; Cao Q; Zhang Q
    Cell Physiol Biochem; 2018; 50(3):1140-1153. PubMed ID: 30355907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD.
    Molina-Pinelo S; Pastor MD; Suarez R; Romero-Romero B; González De la Peña M; Salinas A; García-Carbonero R; De Miguel MJ; Rodríguez-Panadero F; Carnero A; Paz-Ares L
    Eur Respir J; 2014 Jun; 43(6):1740-9. PubMed ID: 24743967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of multi-microarray datasets to identify chronic obstructive pulmonary disease-related miRNAs.
    Hua L; Zheng W; Xia H; Zhou P; An L
    Biomed Mater Eng; 2015; 26 Suppl 1():S1903-15. PubMed ID: 26405964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease.
    Song J; Wang QH; Zou SC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4319-4324. PubMed ID: 30024625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
    Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
    Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.
    Ikari J; Nelson AJ; Obaid J; Giron-Martinez A; Ikari K; Makino F; Iwasawa S; Gunji Y; Farid M; Wang X; Basma H; Demeo D; Feghali-Bostwick C; Holz O; Rabe K; Liu X; Rennard SI
    PLoS One; 2017; 12(9):e0184039. PubMed ID: 28880936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked TGF-β-regulated miRNA expression changes in both COPD and control lung fibroblasts.
    Ong J; Faiz A; Timens W; van den Berge M; Terpstra MM; Kok K; van den Berg A; Kluiver J; Brandsma CA
    Sci Rep; 2019 Dec; 9(1):18214. PubMed ID: 31796837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD.
    Leuenberger C; Schuoler C; Bye H; Mignan C; Rechsteiner T; Hillinger S; Opitz I; Marsland B; Faiz A; Hiemstra PS; Timens W; Camici GG; Kohler M; Huber LC; Brock M
    J Mol Med (Berl); 2016 Jun; 94(6):725-34. PubMed ID: 26864305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.